140
Participants
Start Date
July 31, 2004
Study Completion Date
June 30, 2006
Fragmin (dalteparin sodium)
Queen Elizabeth II Health Science Centre, Halifax
Hamilton Health Science Centre - Hamilton General Hospital, Hamilton
Hamilton Health Science Centre - McMaster University, Hamilton
St Joseph's HealthCare, Hamilton
Hamilton Health Science Centre - Henderson Hospital, Hamilton
Ottawa General Hospital, Ottawa
Ottawa Civic Hospital, Ottawa
Sunnybrook and Women's College Health Science Centre, Toronto
Mount Sinai Hospital, Toronto
University Health Network - Toronto General Hospital, Toronto
University Health Network - Toronto Western Hospital, Toronto
Hopital Charles LeMoyne, Greenfield Park
Hopital Maisonneuve Rosemont, Montreal
Hopital Sacre Couer, Montreal
Collaborators (1)
Canadian Critical Care Trials Group
OTHER
Pfizer
INDUSTRY
Hamilton Health Sciences Corporation
OTHER